Expectations trend
FY2028 · fiscal year ending 2028-05-31 · fmp
NYSEConsumer StaplesPackaged FoodsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.16 → 3.16 EPS · FY ending May 31, 2028 · 10 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 10 to 10; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for GIS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Achieve $750 million cost savings in fiscal 2027 | A primary condition in General Mills's published investment case. The stated target is >=750000000 USD. | Improving | cost savings fall below $750 million in fiscal 2027 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 7 of 8 supplied quarters. Management reported: “Targeting $3 Billion in Cost Savings by Fiscal 2030 In an effort to help address input cost inflation, fund growth investments, and deliver accelerated profit and cash flow growth, General Mills announced that it expects to generate $3 billion in cumulative cost savings in the four years through fiscal 2030.” “General Mills expects to generate at least $750 million in total savings in fiscal 2027 toward this $3 billion target.” |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-05-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
GIS is a mature Consumer Staples business with a recovery-and-execution thesis, rather than a clear growth story. The thesis is in a watch state: recent momentum improved and earnings beats were reported, but performance remains below its industry cohort.
GIS is described as cheap versus peers, while the priced-in tag says its valuation is justified and the expectations gap is small. The evidence does not point to a large market expectation that results will improve; weak execution remains a concern, but overall fragility is rated low.
Near term, fiscal 2027 guidance calls for organic net sales between a 1.5% decline and 0.5% growth, after a 3% decline in 2026-Q3. Management continues to prioritize volume-led growth and cost savings, but progress is limited: adjusted operating margins have declined and fiscal 2026 free cash flow conversion was 85%, below the 95% goal. Recent earnings beats and higher momentum are encouraging, though the CEO transition and a history of misses leave execution risk in view.
The multi-year thesis depends on whether volume-led sales growth returns and whether cost savings improve margins without weakening the business. A guidance cut would be a negative near-term signal, while continued earnings strength from sector peers could support the Consumer Staples backdrop. A weakening jobs trend is another risk, though the evidence notes that recession fears can weigh on the sector.
Over the next 1 to 3 years, GIS has a modestly supportive sector backdrop and a low peer valuation, but the case still depends on better sales execution, margin delivery, and cash conversion. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
EPS around $3.1 in fiscal 2027 | Recent earnings beat estimates with EPS guidance around $3.1 for fiscal 2027. | Intact | EPS guidance falls below $3.0 for fiscal 2027 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain free cash flow conversion at least 95% | Free cash flow conversion aims to reach 95% to support shareholder returns. | Intact | free cash flow conversion falls below 85% next fiscal year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 5 of 8 supplied quarters. Management reported: “• Free cash flow conversion is expected to be approximately 95 percent of adjusted after-tax earnings.” “• Free cash flow conversion is expected to be at least 95 percent of adjusted after-tax earnings.” Delivery assessment Nov 4, 2026 |
Restore volume-driven organic net sales growth | New product launches and pet food growth help restore sales. | Under Pressure | organic volume growth remains negative over next 4 quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.21 → $3.16 · observed estimates
$17.93B → $17.76B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-07-25 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-07-26 | $3.21 | $17,931,708,920 | 18 / 15 |
| 2026-07-27 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-07-28 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-07-29 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-07-30 | $3.21 | $17,931,708,920 | 18 / 15 |
| 2026-07-31 | $3.21 | $17,931,708,920 | 18 / 15 |
| 2026-08-01 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-08-02 | $3.21 | $17,931,708,920 | 18 / 15 |
| 2026-08-03 | $3.21 | $17,931,708,920 | 18 / 15 |
| 2026-08-04 | $3.21 | $17,931,708,920 | 18 / 15 |
| 2026-08-05 | $3.21 | $17,931,708,920 | 18 / 15 |
| 2026-08-06 | $3.21 | $17,931,708,920 | 18 / 15 |
| 2026-08-07 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-08-08 | $3.21 | $17,931,708,920 | 18 / 15 |
| 2026-08-09 | $3.21 | $17,931,708,920 | 18 / 15 |
| 2026-08-10 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-08-12 | $3.21 | $17,931,708,920 | 18 / 15 |
| 2026-08-13 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-08-14 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-08-15 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-08-16 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-08-17 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-08-18 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-08-19 | $3.21 | $17,933,429,730 | 10 / 12 |
| 2026-08-20 | $3.21 | $17,931,019,375 | 10 / 12 |
| 2026-08-21 | $3.21 | $17,931,019,375 | 10 / 12 |
| 2026-08-22 | $3.21 | $17,931,019,375 | 10 / 12 |
| 2026-08-23 | $3.21 | $17,931,019,375 | 10 / 12 |
| 2026-08-24 | $3.21 | $17,931,019,375 | 10 / 12 |
| 2026-08-25 | $3.21 | $17,931,019,375 | 10 / 12 |
| 2026-08-26 | $3.21 | $17,936,319,375 | 10 / 12 |
| 2026-08-27 | $3.21 | $17,936,319,375 | 10 / 12 |
| 2026-08-28 | $3.21 | $17,936,319,375 | 10 / 12 |
| 2026-08-29 | $3.21 | $17,936,319,375 | 10 / 12 |
| 2026-08-30 | $3.21 | $17,936,319,375 | 10 / 12 |
| 2026-08-31 | $3.21 | $17,936,319,375 | 10 / 12 |
| 2026-09-01 | $3.21 | $17,936,319,375 | 10 / 12 |
| 2026-09-02 | $3.21 | $17,939,586,042 | 10 / 13 |
| 2026-09-03 | $3.21 | $17,941,336,375 | 10 / 13 |
| 2026-09-04 | $3.21 | $17,941,336,375 | 9 / 13 |
| 2026-09-05 | $3.21 | $17,941,336,375 | 10 / 13 |
| 2026-09-06 | $3.21 | $17,941,336,375 | 10 / 13 |
| 2026-09-07 | $3.21 | $17,941,336,375 | 10 / 13 |
| 2026-09-08 | $3.21 | $17,941,336,375 | 10 / 13 |
| 2026-09-09 | $3.21 | $17,941,336,375 | 10 / 13 |
| 2026-09-10 | $3.21 | $17,941,336,375 | 10 / 13 |
| 2026-09-11 | $3.21 | $17,918,427,383 | 10 / 13 |
| 2026-09-12 | $3.21 | $17,922,627,383 | 10 / 13 |
| 2026-09-13 | $3.21 | $17,922,627,383 | 10 / 13 |
| 2026-09-14 | $3.21 | $17,922,627,383 | 10 / 13 |
| 2026-09-15 | $3.21 | $17,922,200,716 | 10 / 13 |
| 2026-09-16 | $3.21 | $17,922,200,716 | 10 / 13 |
| 2026-09-17 | $3.21 | $17,938,592,974 | 10 / 13 |
| 2026-09-18 | $3.21 | $17,938,592,974 | 10 / 13 |
| 2026-09-19 | $3.21 | $17,938,592,974 | 10 / 13 |
| 2026-09-20 | $3.19 | $17,938,359,574 | 10 / 13 |
| 2026-09-21 | $3.19 | $17,938,386,241 | 10 / 13 |
| 2026-09-22 | $3.19 | $17,938,386,241 | 10 / 13 |
| 2026-09-23 | $3.19 | $17,938,386,241 | 10 / 13 |
| 2026-09-24 | $3.19 | $17,938,386,241 | 10 / 13 |
| 2026-09-25 | $3.16 | $17,760,752,384 | 10 / 14 |
| 2026-09-26 | $3.16 | $17,760,752,384 | 10 / 14 |
| 2026-09-27 | $3.16 | $17,760,752,384 | 10 / 14 |
| 2026-09-28 | $3.16 | $17,760,752,384 | 10 / 14 |
| 2026-09-29 | $3.16 | $17,760,752,384 | 10 / 14 |
| 2026-09-30 | $3.16 | $17,760,752,384 | 10 / 14 |
| 2026-10-01 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-02 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-03 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-04 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-05 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-06 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-07 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-08 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-09 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-10 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-11 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-12 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-13 | $3.16 | $17,761,027,384 | 10 / 14 |
| 2026-10-14 | $3.16 | $17,761,028,890 | 10 / 14 |
| 2026-10-15 | $3.16 | $17,761,028,890 | 10 / 14 |
| 2026-10-16 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-17 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-18 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-19 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-20 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-21 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-22 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-23 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-24 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-25 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-26 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-27 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-28 | $3.16 | $17,759,653,890 | 10 / 14 |
| 2026-10-29 | $3.16 | $17,759,647,640 | 10 / 14 |
| 2026-10-30 | $3.16 | $17,759,647,640 | 10 / 14 |
| 2026-10-31 | $3.16 | $17,759,647,640 | 10 / 14 |
| 2026-11-01 | $3.16 | $17,759,647,640 | 10 / 14 |
| 2026-11-02 | $3.16 | $17,759,647,640 | 10 / 14 |
| 2026-11-03 | $3.16 | $17,759,647,640 | 10 / 14 |
| 2026-11-04 | $3.16 | $17,759,647,640 | 10 / 14 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 4 Buy / Strong Buy · 12 Hold · 4 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Dec 16, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.